在住院的背景下对痴呆症友好:使用沃克和阿万特方法进行概念分析
Ellen Munsterman1, Adriana Perez1, Nancy Hodgson1
1University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Journal of advanced nursing
|March 4, 2024
概括
这项研究定义了"痴呆症友好的"住院治疗,确定了工作人员培训和以人为中心的护理等关键要素. 清晰的定义有助于医院和研究人员在住院期间改善痴呆症护理.
科学领域:
- 老年学是指老年学的学科.
- 护理科学 护理科学
- 医疗保健管理的管理
背景情况:
- 住院治疗对于痴呆症患者来说是一个独特的挑战.
- 在医院环境中缺乏"痴呆症友好"的明确,标准化的定义.
- 医院对痴呆症护理的现有方法存在很大差异.
研究的目的:
- 进行全面的文献审查,在住院治疗的背景下建立"痴呆症友好"的概念定义.
- 识别和阐述构成痴呆症友好的医院环境的核心属性.
- 为开发和评估在急性护理机构中对痴呆症友好的干预措施提供基础.
主要方法:
- 使用已建立的沃克和阿万特方法进行概念分析.
- 在2022年6月和2023年2月进行的主要数据库 (Scopus,PubMed,CINAHL,PsycINFO,AGELINE) 的系统文献搜索.
- 综合识别的属性,以制定一个概念定义.
主要成果:
- 确定了有助于痴呆症友好的住院治疗的五个关键属性:员工知识和教育,环境修改,以人为中心的护理方法,特定的护理护理交付策略和家庭护理人员的纳入.
- 这些属性构成了提出的概念定义的基础.
- 这些发现强调了为痴呆症患者创造支持性的医院环境的多面性.
结论:
- 对"痴呆症友好"住院的精细概念定义对于一致的理解和应用至关重要.
- 这一定义将指导医疗机构实施有效的痴呆症友好性实践和干预措施.
- 澄清的概念将加强研究工作,重点关注痴呆症友好的医院计划的影响和有效性.
相关概念视频
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
Documentation in Long-Term and Home Healthcare Setting
890
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
890
Alzheimer's Disease: Overview
481
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
481
Alzheimer's Disease: Treatment
188
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
188


